Pathogenesis and treatment of oral candidosis

Journal of Oral Microbiology

Volumn 3, Issue 2011, 2011, Pages

  Williams, David ^a   Lewis, Michael ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Candida; Oral candidosis

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CLOTRIMAZOLE; ECHINOCANDIN; ESSENTIAL OIL; FLUCONAZOLE; FLUCYTOSINE; HEMOLYSIN; HISTATIN; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; NYSTATIN; POLYENE ANTIBIOTIC AGENT; POSACONAZOLE; SILANE DERIVATIVE; STEROID; TRICLOSAN; VIRULENCE FACTOR; VORICONAZOLE;

ACUTE ERYTHEMATOUS CANDIDOSIS; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ASTHMA; BIOFILM; CANDIDA; CANDIDIASIS; CHRONIC ERYTHEMATOUS CANDIDOSIS; DISEASE CLASSIFICATION; DRUG ABSORPTION; DRUG FORMULATION; FUNGAL VIRULENCE; HUMAN; IMMUNE RESPONSE; MOUTH HYGIENE; MUCOSAL IMMUNITY; NONHUMAN; ORAL CANDIDOSIS; PATHOGENESIS; PSEUDOMEMBRANOUS CANDIDOSIS; REVIEW; RISK FACTOR; STOMATITIS; SYMPTOMATOLOGY; THRUSH;

EID: 79959771340     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v3i0.5771     Document Type: Review

References (109)

1. Brandaõ LR, Medeiros AO, Duarte MC, Barbosa AC, Rosa CA. Diversity and antifungal susceptibility of yeasts isolated by multiple-tube fermentation from three freshwater lakes in Brazil. J Water Health 2010; 8: 279-89.
2. Hsieh CW, Huang LY, Tschen EF, Chang CF, Lee CF. Five novel anamorphic, ascomycetous yeast species associated with mushrooms and soil. FEMS Yeast Res 2010; 10: 948-56.
3. Edelmann A, Krüger M, Schmid J. Genetic relationship between human and animal isolates of Candida albicans. J Clin Microbiol 2005; 43: 6164-6.
4. Schauer F, Hanschke R. Taxonomy and ecology of the genus Candida. Mycoses 1999; 42: 12-21.
5. Martins M, Henriques M, Ribeiro AP, Fernandes R, Gonçalves V, Seabra A, et al. Oral Candida carriage of patients attending a dental clinic in Braga, Portugal. Rev Iberoam Micol 2010; 27: 119-24.
6. Meurman JH, Pärnänen P, Seneviratne CJ, Samaranayake LP, Saarinen AM, Kari K. Prevalence and antifungal drug sensitivity of non-albicans Candida in oral rinse samples of self-caring elderly. Gerodontology 2010. doi: 10.1111/j.1741-2358.2010.00407.x
7. Vanden Abbeele A, de Meel H, Ahariz M, Perraudin JP, Beyer I, Courtois P. Denture contamination by yeasts in the elderly. Gerodontology 2008; 25: 222-8.
8. Fisher BM, Lamey PJ, Samaranayake LP, MacFarlane TW, Frier BM. Carriage of Candida species in the oral cavity in diabetic patients: relationship to glycaemic control. J Oral Pathol 1987; 16: 282-4.
9. Sio JO, Minwalla FK, George RH, Booth IW. Oral candida: is dummy carriage the culprit? Arch Dis Child 1987; 62: 406-20.
10. Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Magaró HM. Oral yeast carriage in HIV-infected and noninfected populations in Rosario, Argentina. Mycoses 2009; 52: 53-9.
11. Liguori G, Lucariello A, Colella G, De Luca A, Marinelli P. Rapid identification of Candida species in oral rinse solutions by PCR. J Clin Pathol 2007; 60: 1035-9.
12. Back-Brito GN, Mota AJ, Vasconcellos TC, Querido SM, Jorge AO, Reis AS, et al. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia 2009; 167: 81-7.
13. Odds FC. Candida and candidiasis. London: Balliere Tindall; 1988.
14. Campisi G, Panzarella V, Matranga D, Calvino F, Pizzo G, Lo Muzio L, et al. Risk factors of oral candidosis: a twofold approach of study by fuzzy logic and traditional statistic. Arch Oral Biol 2008; 53: 388-97.
15. Fukushima C, Matsuse H, Saeki S, Kawano T, Machida I, Kondo Y, et al. Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma 2005; 42: 601-4.
16. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90: 646-51.
17. Radfar L, Shea Y, Fischer SH, Sankar V, Leakan RA, Baum BJ, et al. Fungal load and candidiasis in Sjogrens syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 283-7.
18. Ohman SC, Jontell M. Treatment of angular cheilitis: the significance of microbial analysis, antimicrobial treatment, and interfering factors. Acta Odontol Scand 1988; 46: 267-72.
19. Weerasuriya N, Snape J. Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 2008; 25: 119-30.
20. Soysa NS, Samaranayake LP, Ellepola AN. Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med 2006; 23: 455-9.
21. Egusa H, Soysa NS, Ellepola AN, Yatani H, Samaranayake LP. Oral candidosis in HIV-infected patients. Curr HIV Res 2008; 6: 485-99.
22. Soysa NS, Samaranayake LP, Ellepola AN. Antimicrobials as a contributory factor in oral candidosis - a brief overview. Oral Dis 2008; 14: 138-43.
23. Samaranayake LP. Nutritional factors and oral candidosis. J Oral Pathol 1986; 15: 61-5.
24. Vazquez JA. Invasive fungal infections in the intensive care unit. Semin Respir Crit Care Med 2010; 31: 79-86.
25. de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 2004; 17: 729-59.
26. Thompson GR III, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J, et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 488-95.
27. Zomorodian K, Haghighi NN, Rajaee N, Pakshir K, Tarazooie B, Vojdani M, et al. Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers. Med Mycol 2011; 49: 208-11.
28. Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 2008; 36: 2034-9.
29. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-60.
30. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: e954-66.
31. McCullough MJ, Savage NW. Oral candidosis and the therapeutic use of antifungal agents in dentistry. Aust Dent J 2005; 50: S36-9.
32. Reichart PA, Samaranayake LP, Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis 2000; 6: 85-91.
33. Thomas MS, Parolia A, Kundabala M, Vikram M. Asthma and oral health: a review. Aust Dent J 2010; 55: 128-33.
34. Reichart PA. Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma. Med Microbiol Immunol 2003; 192: 165-9.
35. Gabler IG, Barbosa AC, Velela RR, Lyon S, Rosa CA. Incidence and anatomic localization of oral candidiasis in patients with AIDS hospitalized in a public hospital in Belo Horizonte, MG, Brazil. J Appl Oral Sci 2008; 16: 247-50.
36. Hodgson TA, Rachanis CC. Oral fungal and bacterial infections in HIV-infected individuals: an overview in Africa. Oral Dis 2002; 8: 80-7.
37. Holmstrup P, Besserman M. Clinical, therapeutic and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol 1983; 56: 388-95.
38. Arendorf TM, Walker DM, Kingdom RJ, Roll JRS, Newcombe RG. Tobacco smoking and denture wearing in oral candidal leukoplakia. Br Dent J 1983; 155: 340-3.
39. Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/ candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 2003; 14: 253-67.
40. Cawson RA, Binnie WH. Candidal leukoplakia and carcinoma. A possible relationship. In: Mackenzie IA, Dabelsteen E, Squier C, eds. Oral premalignancy. Iowa City: University of Iowa Press; 1980. p. 59-66.
41. Krogh P, Hald B, Holmstrup P. Possible mycologic aetiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 1987; 8: 1543-8.
42. Dias AP, Samaranayake LP. Clinical, microbiological and ultrastructural features of angular cheilitis lesions in Southern Chinese. Oral Dis 1995; 1: 43-8.
43. Reamy BV, Derby R, Bunt CW. Common tongue conditions in primary care. Am Fam Physician 2010; 81: 627-34.
44. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Aust Dent J 1998; 43: 160-6.
45. Radford DR, Challacombe SJ, Walter JD. Denture plaque and adherence of Candida albicans to denture-base materials in vivo and in vitro. Crit Rev Oral Biol Med 1999; 10: 99-116.
46. Grbic JT, Mitchell-Lewis DA, Fine JB, Phelan JA, Bucklan RS, Zambon JJ, et al. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 1995; 66: 30-7.
47. Velegraki A, Nicolatou O, Theodoridou M, Mostrou G, Legakis NJ. Paediatric AIDS - related linear gingival erythema: a form of erythematous candidiasis? J Oral Pathol Med 1999; 28: 178-82.
48. Eyerich K, Eyerich S, Hiller J, Behrendt H, Traidl-Hoffmann C. Chronic mucocutaneous candidiasis, from bench to bedside. Eur J Dermatol 2010; 20: 260-5.
49. Liu X, Hua H. Oral manifestation of chronic mucocutaneous candidiasis: seven case reports. J Oral Pathol Med 2007; 36: 528-32.
50. Cotter G, Kavanagh K. Adherence mechanisms of Candida albicans. Br J Biomed Sci 2000; 57: 241-9.
51. Hazen KC. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells. Infect Immun 1989; 57: 1894-900.
52. Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol 2001; 9: 176-80.
53. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999; 283: 1535-8.
54. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. Interaction of Candida albicans cell-wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed species communities. Infect Immun 2010; 78: 4644-52.
55. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006; 6: 979-86.
56. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J. In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol 2010; 61: 534-40.
57. Rajendran R, Robertson DP, Hodge PJ, Lappin DF, Ramage G. Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes. Mycopathologia 2010; 170: 229-35.
58. Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 2010; 202: 171-5.
59. Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000; 19: 1-8.
60. Verran J, Maryan CJ. Retention of Candida albicans on acrylic resin and silicone of different surface topography. J Prosthet Dent 1997; 77: 535-9.
61. Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol 2004; 12: 317-24.
62. Jackson AP, Gamble JA, Yeomans T, Moran GP, Saunders D, Harris D, et al. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res 2009; 19: 2231-44.
63. Kumamoto CA, Vinces MD. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 2005; 7: 1546-54.
64. Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994; 23: 406-12.
65. Morschhäuser J. Regulation of white-opaque switching in Candida albicans. Med Microbiol Immunol 2010; 199: 165-72.
66. Soll DR. Why does Candida albicans switch? FEMS Yeast Res 2009; 9: 973-89.
67. Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 2004; 6: 915-26.
68. Hube B, Sanglard D, Odds FC, Hess D, Monod M, SchaferW, et al. Disruption of each of the secreted aspartyl protease genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun 1997; 65: 3529-38.
69. Chen YC, Wu CC, Chung WL, Lee FJ. Differential secretion of Sap4-6 proteins in Candida albicans during hyphae formation. Microbiology 2002; 148: 3743-54.
70. Hattori M, Yoshiura K, Negi M, Ogawa H. Keratinolytic proteinase produced by Candida albicans. Sabouraudia 1984; 22: 175-83.
71. Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol 1994; 31: S2-5.
72. Gropp K, Schild L, Schindler S, Hube B, Zipfel PF, Skerka C. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 2009; 47: 465-75.
73. Reinholdt J, Krogh P, Holmstrup P. Degradation of IgA1, IgA2, and S-IgA by Candida and Torulopsis species. Acta Pathol Microbiol Immunol Scand C 1987; 95: 265-74.
74. Rüchel R. On the role of proteinases from Candida albicans in the pathogenesis of acronecrosis. Zentralbl Bakteriol Mikrobiol Hyg A 1983; 255: 524-36.
75. Rüchel R. Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci 1986; 3: 316-9.
76. Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 2007; 56: 1393-8.
77. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48: 365-77.
78. Fu Y, Ibrahim AS, Fonzi W, Zhou X, Ramos CF, Ghannoum MA. Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology 1997; 143: 331-40.
79. Paraje MG, Correa SG, Albesa I, Sotomayor CE. Lipase of Candida albicans induces activation of NADPH oxidase and Larginine pathways on resting and activated macrophages. Bioche Biophys Res Commun 2009; 390: 263-8.
80. Stehr F, Felk A, Gácser A, Kretschmar M, Mähnss B, Neuber K, et al. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res 2004; 4: 401-8.
81. Luo G, Samaranayake LP, Yau JYY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 2001; 39: 2971-4.
82. Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun 1994; 62: 5154-6.
83. Mukhopadhyay S, Herre J, Brown GD, Gordon S. The potential for Toll-like receptors to collaborate with other innate immune receptors. Immunology 2004; 112: 521-30.
84. Bonifazi P, Zelante T, D'Angelo C, De Luca A, Moretti S, Bozza S, et al. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol 2009; 2: 362-74.
85. Jouault T, Sarazin A, Martinez-Esparza M, Fradin C, Sendid B, Poulain D. Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cell Microbiol 2009; 11: 1007-15.
86. Gil ML, Gozalbo D. Role of Toll-like receptors in systemic Candida albicans infections. Front Biosci 2009; 14: 570-82.
87. Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM, et al. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 2009; 15: 2531-40.
88. Del Prete A, Vermi W, Dander E, Otero K, Barberis L, Luini W, et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. Embo J 2004; 23: 3505-15.
89. Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, et al. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin Exp Immunol 2008; 154: 406-14.
90. Conti HR, Gaffen SL. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect 2010; 12: 518-27.
91. Mohammadi Z, Abbott PV. The properties and applications of chlorhexidine in endodontics. Int Endod J 2009; 42: 288-302.
92. Hope CK, Wilson M. Effects of dynamic fluid activity from an electric toothbrush on in vitro oral biofilms. J Clin Periodontol 2003; 30: 624-9.
93. Filoche SK, Soma K, Sissons CH. Antimicrobial effects of essential oils in combination with chlorhexidine digluconate. Oral Microbiol Immunol 2005; 20: 221-5.
94. Fine DH. Mouth rinses as adjuncts for plaque and gingivitis management. A status report for the American Journal of Dentistry. Am J Dent 1988; 1: 259-63.
95. Sanglard D, Bille J. Current understanding of the modes of action of and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections. In: Calderone RA, ed. Candida and candidiasis. Washington, DC: ASM Press; 2002. p. 349-83.
96. Andes D. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob Agents Chemother 2003; 47: 1179-86.
97. Nimmi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology 2010; 98: 15-25.
98. Force RW, Nahata MC. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother 1995; 29: 10-5.
99. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002; 46: 1704-13.
100. Redding SW, Kirkpatrick WR, Dib O, Fothergill AW, Rinaldi MG, Patterson TF. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dentist 2000; 20: 178-81.
101. Bal AM. The echinocandins: three useful choices or three too many? Int J Antimicrob Agents 2010; 35: 13-8.
102. Chandra J, Patel JD, Li J, Zhou G, Mukherjee PK, McCormick TS, et al. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 2005; 71: 8795-801.
103. Price CL, Williams DW, Waters MG, Coulthwaite L, Verran J, Taylor RL, et al. Reduced adherence of Candida to silanetreated silicone rubber. J Biomed Mater Res B Appl Biomater 2005; 74: 481-7.
104. Pusateri CR, Monaco EA, Edgerton M. Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine. Arch Oral Biol 2009; 54: 588-94.
105. Redding S, Bhatt B, Rawls HR, Siegel G, Scott K, Lopez-Ribot J. Inhibition of Candida albicans biofilm formation on denture material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 669-72.
106. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002; 46: 3634-6.
107. Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 2005; 113: 188-96.
108. Van der Mei HC, Free RH, Elving GJ, Van Weissenbruch R, Albers FW, Busscher HJ. Effect of probiotic bacteria on prevalence of yeasts in oropharyngeal biofilms on silicone rubber voice prostheses in vitro. J Med Microbiol 2000; 49: 713-8.
109. Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, et al. Probiotics reduce the prevalence of oral Candida in the elderly - a randomized controlled trial. J Dent Res 2007; 86: 125-30.